Form D · Biotechnology

Invisible Sentinel, Inc.

Philadelphia, PA · CIK 0001459223

Offering snapshot reported Apr 18, 2017 · SEC filing

Reported sold
$7.62M
Offering amount: $9M
Investors reported
27
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 3, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 18, 2017Initial$7,616,447No comparison27SEC filing
Jan 14, 2014Initial$6,869,826No comparison22SEC filing
Dec 3, 2010Initial$2,000,000No comparison3SEC filing
Mar 27, 2009Initial$1,025,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-285020

Source: Form D, filed Apr 18, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Greg Betzler Director
John Blair Director
Jonathan Blair Director
Roger Hochstin Director
Adam Carl Joelsson Executive, Promoter
Brian Mc Elwee Director
Benjamin Joseph Pascal Director, Executive
Bruce Peacock Director
Nicholas Anthony Siciliano Director, Executive
Adam Eugene Snook Executive, Promoter
Paul Joseph Touhey Director, Executive
Michael F. Young Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3711 Market Street, Suite 900
Philadelphia, PA, 19104